CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 117 filers reported holding CUREVAC N V in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,361,423 | -27.4% | 199,330 | +10.8% | 0.00% | – |
| Q2 2023 | $1,875,308 | +60.9% | 179,972 | +7.6% | 0.00% | – |
| Q1 2023 | $1,165,397 | +116323.3% | 167,202 | +0.7% | 0.00% | – |
| Q4 2022 | $1,001 | -99.9% | 166,014 | +9.3% | 0.00% | – |
| Q3 2022 | $1,196,000 | -41.3% | 151,822 | +1.5% | 0.00% | – |
| Q2 2022 | $2,036,000 | -67.2% | 149,635 | -52.8% | 0.00% | -100.0% |
| Q1 2022 | $6,211,000 | -40.0% | 316,776 | +5.0% | 0.00% | 0.0% |
| Q4 2021 | $10,350,000 | -35.2% | 301,663 | +3.2% | 0.00% | -50.0% |
| Q3 2021 | $15,964,000 | -23.4% | 292,287 | +3.0% | 0.00% | -33.3% |
| Q2 2021 | $20,854,000 | +63.5% | 283,817 | +103.5% | 0.00% | +50.0% |
| Q1 2021 | $12,757,000 | +21.1% | 139,486 | +7.4% | 0.00% | 0.0% |
| Q4 2020 | $10,533,000 | +72.9% | 129,931 | -0.7% | 0.00% | +100.0% |
| Q3 2020 | $6,092,000 | – | 130,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |